pharmaphorum

OCTOBER 7, 2020

OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies. Value in healthcare is a continually changing concept. The post Responding to dynamic shifts in value communications appeared first on.

Communication 68

Communication Pharmaceutical Companies Pharmaceutical Companies 68

pharmaphorum

JANUARY 15, 2021

As new approaches to healthcare attainment take hold there will be some degree of uncertainty among pharmaceutical companies about where they fit into the new structures and the holistic care they seek to provide.

Pharmaceutical Companies 68

Pharmaceutical Companies Pharmaceutical Companies 68

Pharma Marketing Network

MARCH 23, 2023

Pharmaceutical advertising is a crucial aspect of promoting and marketing drugs to the public. With the increase in competition, it has become essential for pharmaceutical companies to find the most effective methods of advertisement to reach their target audience. billion in the US alone.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

NOVEMBER 3, 2020

During the ASCO 2020 Annual Meeting, just 16% of respondents visited virtual booths or exhibits from pharmaceutical companies. So, how can pharmaceutical companies create an impactful virtual congress experience? Download the rest of the article here.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

DECEMBER 9, 2020

The COVID-19 pandemic has been mainstream headline news throughout 2020 and continues to have a profound impact on all our lives. Prominent industry figures, such as oncologist and ex-director of the WHO Cancer Programme Professor Karol Sikora, shared news articles and utilised their networks to raise awareness of decreased cancer diagnosis.

Hospitals 124

Hospitals Clinic Management Pharmaceutical Companies Pharmaceutical Companies 124

European Pharmaceutical Review

JANUARY 25, 2024

11 This requirement directly contradicts what is included in Article 63. 12 Print on demand: impact on pharmacies and workflow Article 63(3) of the Directive proposal stipulates that, in cases where paper leaflets have been removed, patients should be guaranteed a paper leaflet upon request in the pharmacy. Article 63 PGEU (2023).

Packaging 86

Packaging Documentation Pharmaceutical Companies Pharmaceutical Companies 86

pharmaphorum

MAY 13, 2022

In my last article, I outlined the inflection point facing the pharmaceutical industry in digital health and the digital transformation of its clinical and commercial operations. This time I’m going to focus on one company and its view on pharma’s digital commercial strategy. Digital fluency and change.

Pharmaceutical Companies 130

Pharmaceutical Companies Pharmaceutical Companies Vaccines FDA 130

Pharma Marketing Network

JANUARY 6, 2021

Throughout the year 2020, pharma marketers were forced to explore new strategies in order to keep up with the many evolving trends. Throughout 2020, the use of telehealth and remote monitoring has also drastically increased and may continue to be popular tools used between patients and HCPs in the year 2021.

Communication 98

Communication Vaccines Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

JANUARY 22, 2021

In this article, we focus in particular on how COVID-19 may be changing prescribing decisions using market research and claims data. Source: CRA market research (conducted June 2020). Source: CRA claims data analysis (using claims through June 2020). Changes in Prescribing by Specialty. Changes in Prescribing by Specialty.

Specialty Pharmacies 104

Specialty Pharmacies Pharmaceutical Companies Pharmaceutical Companies Vaccines 104

Pharma Marketing Network

AUGUST 26, 2020

In office/in person sales promotion, the staple of pharmaceutical company activities, is simply not possible today with interactions reduced to the sporadic video or to telephone engagement. This will result in permanent shifts in how HCPs and patients interact with pharmaceutical companies.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Vaccines Compounding 98

European Pharmaceutical Review

OCTOBER 19, 2022

Patents are often described as the ‘lifeblood’ of pharmaceutical companies. 1 However, patent protection for pharmaceutical products is an economic trade-off between providing monopoly rights that incentivise development of future products and permitting higher drug prices to recoup the investment. 2020-02-24.

FDA 78

FDA Dosage Pharmaceutical Companies Pharmaceutical Companies 78

Roots Analysis

SEPTEMBER 4, 2023

In this article, we will evaluate the overall landscape of companion diagnostics services providers, as well the as the key trends shaping up this segment of the market. During our research, we identified around 150 players (CROs / CDOs / diagnostics developers) that offer companion diagnostics services.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies FDA 52

Pharma Marketing Network

DECEMBER 17, 2021

The wave of interest in sustainability follows the value chain from top-tier pharmaceutical companies to their suppliers of every size. About 80% of pharmaceutical companies have announced a commitment to becoming carbon-neutral or made a net-zero pledge for carbon emissions. Where do most organizations start?

Pharmaceutical Companies 103

Pharmaceutical Companies Pharmaceutical Companies Communication 103

pharmaphorum

SEPTEMBER 18, 2020

“Picking the next merger candidate is hard enough, doing so before everyone else jumps on board, then picking the right time to sell makes for a dangerous investment game,” said one BBC News article from December 1998. Blockbusters go off patent. The deal was instantly controversial in both Europe and the US. COVID-19 and beyond.

Vaccines 115

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 115

pharmaphorum

FEBRUARY 9, 2022

In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in the oncology sector. The oncology segment has been recognised as one of the most productive areas for pharmaceutical companies to focus their R&D investment.

Vaccines 134

Vaccines Immunization Compounding Pharmaceutical Companies 134

pharmaphorum

APRIL 27, 2022

Likewise, trust in the overall health sector is currently 2 percentage points below January 2020 levels, and far below (11 percentage points) May 2021 levels. As discussed in an earlier article , COVID-19 has polarised the population when it comes to evidence-based medicine and public health.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies 98

The People's Pharmacy

MAY 29, 2023

We also located an article in the Canadian Medical Association Journal (Dec. We first wrote about cimetidine for shingles in 2020. One article described the heartburn medicine Tagamet as having a positive impact. We did, however, find an interesting case series in The New England Journal of Medicine (Feb. Tagamet for Warts?

Immunization 72

Immunization Labelling Pharmaceutical Companies Pharmaceutical Companies 72

The People's Pharmacy

MAY 8, 2023

According to the ProPublica report: “The percentage of overseas manufacturers that hadn’t been inspected within five years, or which have never once been inspected, has grown from 30% in 2020 to more than 80% in 2022.” The article by Sidney Lupkin was titled “Tainted Drugs: When Medicine Makes Patients Sicker.” The FDA ignores us.

FDA 72

FDA Pharmaceutical Companies Pharmaceutical Companies Medical Schools 72

European Pharmaceutical Review

OCTOBER 20, 2022

Annex 1 states that “at least one representative sample is included every day that the water is used for manufacturing processes” Another important aspect of grab sampling is the frequency, which is up to the pharmaceutical company to determine. EU Commission, 2020. 7 also in the scheme of microbial monitoring.

Pharmaceutical Companies 91

Pharmaceutical Companies Pharmaceutical Companies FDA 91

The People's Pharmacy

JUNE 12, 2023

The parties that benefit are the pharmaceutical companies and the pharmacies. The losers are patients, insurance companies and the country as a whole for wasting money on unneeded things. Fortunately, a review from The Medical Letter on Drugs and Therapeutics (July 27, 2020) lays that fear to rest.

Labelling 62

Labelling Mail-Order Pharmacies Adverse Reactions FDA 62

Pharma Marketing Network

DECEMBER 14, 2020

Highlights from Reuters Events, Pharma Awards USA 2020 – Day 1. With access to over 60 of the industry’s shining case studies, the 2020 USA Pharma Awards held its virtual ceremony on December 8-9, 2020. Here are some highlights from day one of the Pharma Awards USA 2020: Most Valuable Collaboration Award.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Patient Care 52

European Pharmaceutical Review

SEPTEMBER 2, 2022

This article explores just one aspect of the RMP, that of RMMs, and how their effectiveness is measured with Dr Sophie Jouaville, an associate principal at IQVIA working on the design and oversight of non-interventional real-world evidence (RWE) safety and health economics and outcomes research (HEOR) studies. US Food and Drug Administration.

Adverse Reactions 78

Adverse Reactions Documentation Medical Schools Packaging 78

pharmaphorum

OCTOBER 7, 2021

Use of these platforms was however already trending up before the crisis, and there’s every sign demand will stay high from now on, according to Sjors van den Camp, commercial director at Online Seminar – a company whose heritage in this sector goes back more than a decade. The crisis that changed everything.

Communication 98

Communication Labelling Pharmaceutical Companies Pharmaceutical Companies 98

Roots Analysis

DECEMBER 18, 2023

The Swedish pharmaceutical company, Oncopeptides was another developer which tapped into the next generation drug conjugate domain. It is worth highlighting that more than 75% of the articles published were focused on the PRRT, followed by GalNac conjugates and ligand mediated RNAi conjugates.

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies 40

pharmaphorum

AUGUST 13, 2020

Of these three societal pillars, it is, perhaps surprisingly, business that has stepped up to the plate most assuredly in 2020 – led by some of the world’s strongest brands. There are many other mega pharmaceutical companies in the kill-COVID game: Johnson & Johnson, Sanofi, AstraZeneca, GSK and Roche included.

Health and Personal Care Stores 111

Health and Personal Care Stores Vaccines Communication Pharmaceutical Companies 111

pharmaphorum

JANUARY 5, 2021

Healthcare systems ended 2020 in a very different place to where they were in 2019, with hospital capacity (and hospital finances) challenges. For pharmaceutical companies there are a number of implications. The EMA’s new medicines evaluation process seems similarly unaffected in 2020.

Hospitals 105

Hospitals Vaccines Pharmaceutical Companies Pharmaceutical Companies 105

European Pharmaceutical Review

NOVEMBER 15, 2022

This article primarily discusses Appendix D5 Testing of Computerized Systems and Appendix M12 Critical Thinking. ISPE GAMP, RDI Good Practice Guide: Data Integrity by Design, ISPE, 2020. The GAMP 5 Second Edition includes: Six completely new appendices. Significant updates to three of the original appendices. References. FDA, 2022. .

Documentation 88

Documentation FDA Pharmaceutical Companies Pharmaceutical Companies 88

Pharma Marketing Network

SEPTEMBER 28, 2020

Matalon’s team created critical practical guidance for every type of client manufacturing, retail pharmaceutical technology, IT, biopharma, and pharmaceutical companies. The questions Pharma companies seek answers to now, and post-Covid -19, include: What will 2021 look like? Will it be a reset of 2020?

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Marketing Network

SEPTEMBER 28, 2020

Matalon’s team created critical practical guidance for every type of client manufacturing, retail pharmaceutical technology, IT, biopharma, and pharmaceutical companies. The questions Pharma companies seek answers to now, and post-Covid -19, include: What will 2021 look like? Will it be a reset of 2020?

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

AUGUST 17, 2020

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. How are regulated industries approaching the personalisation, or even hyper-personalisation, of content?

Communication 97

Communication Insurance Packaging Pharmaceutical Companies 97

pharmaphorum

JANUARY 9, 2023

This article is the first part of three and covers the first three of nine predictions, here focusing on global healthcare environmental challenges and what they mean for the pharmaceutical industry. Some of the more resilient launches since 2020 have had these benefits to health systems. Pharma’s starting to wake up to this.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 98

pharmaphorum

DECEMBER 2, 2020

Similarly, in 2019 Pfizer announced a deal to merge its Upjohn generics business with Mylan, creating a combined company called Viatris. The $12 billion deal was cleared in November 2020, creating a generics behemoth with annual sales of around $19 to $20 billion and operations in 165 markets around the word.

Compounding 128

Compounding Vaccines Pharmaceutical Companies Pharmaceutical Companies 128

pharmaphorum

JANUARY 14, 2021

The customer engagement story of 2020 could be summarised in three themes: trend break, agility and remote interaction. For April 2020 almost all face-to-face contact with healthcare professionals (HCPs) ceased. Up to November, the US and Japan actually saw increases in interactive time in 2020.

Pharmaceutical Companies 71

Pharmaceutical Companies Pharmaceutical Companies Labelling 71

pharmaphorum

SEPTEMBER 3, 2020

In this article, I reflect on how the three COVID crises are reshaping the way in which innovative pharmaceutical companies engage with all their customers, and in particular how they consider their commercial models and innovative launch strategies.

Pharmaceutical Companies 96

Pharmaceutical Companies Pharmaceutical Companies 96

pharmaphorum

JUNE 29, 2022

However, this picture of recovery hides a less positive trend – non-COVID innovative launches from 2020 onwards, have, with certain exceptions, under-performed pre-pandemic benchmarks of launch sales performance in the major countries in the market – that is, the US, EU4+UK, China and Japan. The scope of the problem.

HIV Treatment and Prevention Agents 58

HIV Treatment and Prevention Agents Vaccines Pharmaceutical Companies Pharmaceutical Companies 58

PharmaShots

MAY 1, 2023

Factors like digitalization, patent expiry, growing competition, and others put direct or indirect impacts on the revenue of the companies Ever wondered, why for the past few days our feed has been brimming with layoffs news? The pharmaceutical industry is an ever-growing sector driven by innovation and astounding technology.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Vaccines 40

PharmaShots

MAY 1, 2023

Factors like digitalization, patent expiry, growing competition, and others put direct or indirect impacts on the revenue of the companies Ever wondered, why for the past few days our feed has been brimming with layoffs news? The pharmaceutical industry is an ever-growing sector driven by innovation and astounding technology.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Vaccines 40